Clinical trial
Prognostic Value of Serum GDF-15 and LGALS3BP Levels in Patients With Sepsis: A Prospective Cohort Study
NCT07906561 is registered in ClinicalTrials.gov with Inonu University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognostic Value of Serum GDF-15 and LGALS3BP Levels in Patients With Sepsis: A Prospective Cohort Study
- Lead sponsor
- Inonu University
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 30, 2026
- Completion date
- December 31, 2028
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis, septic shock
Lead sponsor's other trials
Inonu University, most recent start first.
+388 more trials See the organization page
Similar trials
Same condition (Shock, Septic) and phase, most recent start first.
+410 more trials See the condition page